{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:13:40Z","timestamp":1788174820458,"version":"build-2803163510"},"reference-count":166,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004755","name":"EMD Serono","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI167271"],"award-info":[{"award-number":["AI167271"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR065964"],"award-info":[{"award-number":["AR065964"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR078416"],"award-info":[{"award-number":["AR078416"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012051","name":"Lupus Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012416","name":"Inova Health System","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jid.2021.11.031","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T03:03:34Z","timestamp":1641783814000},"page":"793-803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"PB","title":["Type I Interferons in Autoimmunity"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0759-5222","authenticated-orcid":false,"given":"Ruth","family":"Fernandez-Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3532-6660","authenticated-orcid":false,"given":"Timothy B.","family":"Niewold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2021.11.031_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003678","article-title":"Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations","volume":"9","author":"Absher","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jid.2021.11.031_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam8458","article-title":"Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8","volume":"10","author":"Ah Kioon","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2021.11.031_bib3","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/art.39504","article-title":"Genome-wide association study in an Amerindian ancestry population reveals novel systemic lupus erythematosus risk loci and the role of European admixture","volume":"68","author":"Alarc\u00f3n-Riquelme","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib4","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.20999","article-title":"Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort","volume":"52","author":"Alarc\u00f3n-Segovia","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib5","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fimmu.2019.00778","article-title":"Sources of type I interferons in infectious immunity: plasmacytoid dendritic cells not always in the driver's seat","volume":"10","author":"Ali","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ajpath.2015.11.010","article-title":"Dermatomyositis with or without anti-melanoma differentiation-associated gene 5 antibodies: common interferon signature but distinct NOS2 expression","volume":"186","author":"Allenbach","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2021.11.031_bib7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/art.38264","article-title":"Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sj\u00f6gren's syndrome","volume":"66","author":"Altorok","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/art.27224","article-title":"Systemic sclerosis and lupus: points in an interferon-mediated continuum","volume":"62","author":"Assassi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/annrheumdis-2018-214856","article-title":"Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal","volume":"78","author":"Azzouz","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib10","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2021.11.031_bib11","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/art.38038","article-title":"Interferon-\u03b1 induction and detection of anti-ro, anti-la, anti-sm, and anti-rnp autoantibodies by autoantigen microarray analysis in juvenile dermatomyositis","volume":"65","author":"Balboni","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/BOR.0000000000000318","article-title":"Environmental exposures and the development of systemic lupus erythematosus","volume":"28","author":"Barbhaiya","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2133.2002.48901.x","article-title":"Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders","volume":"147","author":"Beretta","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2021.11.031_bib14","article-title":"Contribution of rare genetic variation to disease susceptibility in a large Scandinavian myositis cohort [e-pub ahead of print]","author":"Bianchi","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib15","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/art.24936","article-title":"Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis","volume":"60","author":"Bilgic","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127291","article-title":"The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity","volume":"4","author":"Billi","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2021.11.031_bib17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/joim.13032","article-title":"Environmental factors in the pathogenesis of primary Sj\u00f6gren's syndrome","volume":"287","author":"Bj\u00f6rk","year":"2020","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jid.2021.11.031_bib18","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/annrheumdis-2015-207392","article-title":"The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis","volume":"75","author":"Brkic","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/annrheumdis-2011-200275","article-title":"Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis","volume":"71","author":"Carmona","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2019.10.020","article-title":"How-Kit A, et\u00a0al. MDA5+ dermatomyositis is associated with stronger skin type I interferon transcriptomic signature with upregulation of IFN-\u03ba transcript","volume":"140","author":"Cassius","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.031_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fgene.2019.00223","article-title":"Genome-wide DNA methylation profiles reveal common epigenetic patterns of interferon-related genes in multiple autoimmune diseases","volume":"10","author":"Chen","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.jid.2021.11.031_bib22","article-title":"Genetic association study of TNFAIP3, IFIH1, IRF5 polymorphisms with polymyositis\/dermatomyositis in Chinese Han population","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2021.11.031_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2172-9-43","article-title":"Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis","volume":"9","author":"Chen","year":"2008","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib24","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1002\/art.34571","article-title":"Brief report: IRF5 systemic lupus erythematosus risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in mothers of children with neonatal lupus","volume":"64","author":"Cherian","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib25","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/art.38288","article-title":"Association of Interferon- and transforming growth factor \u03b2-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis","volume":"66","author":"Christmann","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaut.2013.04.003","article-title":"Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in na\u00efve CD4+ T cells from lupus patients","volume":"43","author":"Coit","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jid.2021.11.031_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.immuni.2016.12.014","article-title":"Follicular dendritic cell activation by TLR ligands promotes autoreactive B cell responses","volume":"46","author":"Das","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2021.11.031_bib28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1586\/1744666X.2016.1125782","article-title":"An overview of environmental risk factors in systemic sclerosis","volume":"12","author":"De Martinis","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib29","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41590-019-0386-1","article-title":"Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways [published correction appears in Nat Immunol 2019;20:1556","volume":"20","author":"Der","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib30","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/art.24688","article-title":"STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis","volume":"60","author":"Dieud\u00e9","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib31","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/art.23451","article-title":"Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma","volume":"58","author":"Duan","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib32","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/ard.2009.121400","article-title":"Type I interferon system activation and association with disease manifestations in systemic sclerosis","volume":"69","author":"Eloranta","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib33","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/art.27220","article-title":"A\u00a0four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis","volume":"62","author":"Farina","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2013.03.015","article-title":"Characterization of clinical photosensitivity in cutaneous lupus erythematosus","volume":"69","author":"Foering","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2021.11.031_bib35","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/art.30193","article-title":"Association of a functional IRF7 variant with systemic lupus erythematosus","volume":"63","author":"Fu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib36","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.1233321","article-title":"Interferon-\u03b5 protects the female reproductive tract from viral and bacterial infection","volume":"339","author":"Fung","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jid.2021.11.031_bib37","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/art.39962","article-title":"Anifrolumab, an anti-interferon-\u03b1 receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus","volume":"69","author":"Furie","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib38","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1177\/09612033211014267","article-title":"Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosus","volume":"30","author":"Furie","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.jid.2021.11.031_bib39","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI124466","article-title":"Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus","volume":"129","author":"Furie","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2021.11.031_bib40","doi-asserted-by":"crossref","first-page":"73ra20","DOI":"10.1126\/scitranslmed.3001201","article-title":"Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus","volume":"3","author":"Garcia-Romo","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2021.11.031_bib41","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/ng.468","article-title":"A\u00a0large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus","volume":"41","author":"Gateva","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2021.11.031_bib42","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ng.694","article-title":"A\u00a0genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1","volume":"42","author":"Strange","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2021.11.031_bib43","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.40304","article-title":"Lupus-associated functional polymorphism in PNP causes cell cycle abnormalities and interferon pathway activation in human immune cells","volume":"69","author":"Ghodke-Puranik","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaut.2015.08.004","article-title":"Immunogenetics of systemic lupus erythematosus: a comprehensive review","volume":"64","author":"Ghodke-Puranik","year":"2015","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jid.2021.11.031_bib45","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/bph.12010","article-title":"IFN-\u03b1 subtypes: distinct biological activities in anti-viral therapy","volume":"168","author":"Gibbert","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jid.2021.11.031_bib46","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/ar4492","article-title":"Dose-escalation of human anti-interferon-\u03b1 receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study","volume":"16","author":"Goldberg","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jid.2021.11.031_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000361","article-title":"Functional crosstalk between type I and II interferon through the regulated expression of STAT1","volume":"8","author":"Gough","year":"2010","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jid.2021.11.031_bib48","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1002\/art.24958","article-title":"Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1\/Th2 cytokines","volume":"60","author":"Gourh","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib49","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ng1782","article-title":"A\u00a0common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus","volume":"38","author":"Graham","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2021.11.031_bib50","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jid.2021.11.031_bib51","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1038\/jid.2015.188","article-title":"Suppression of T cell activation and collagen accumulation by an anti-IFNAR1 mAb, anifrolumab, in adult patients with systemic sclerosis","volume":"135","author":"Guo","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.11.031_bib52","first-page":"706825","article-title":"The role of genetic variation near interferon-kappa in systemic lupus erythematosus","volume":"2010","author":"Harley","year":"2010","journal-title":"J\u00a0Biomed Biotechnol"},{"key":"10.1016\/j.jid.2021.11.031_bib53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clim.2016.04.002","article-title":"Klinefelter\u2019s syndrome (47,XXY) is in excess among men with Sj\u00f6gren\u2019s syndrome [published correction appears in Clin Immunol 2016;187:137\u20138]","volume":"168","author":"Harris","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib54","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201138","article-title":"Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus","volume":"218","author":"Hartl","year":"2021","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2021.11.031_bib55","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1038\/s41467-021-23361-z","article-title":"Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus","volume":"12","author":"Hasni","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2021.11.031_bib56","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41586-020-2282-0","article-title":"TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9","volume":"581","author":"Heinz","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jid.2021.11.031_bib57","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3899\/jrheum.081160","article-title":"Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus","volume":"36","author":"Hellquist","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib58","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/ard.2011.150326","article-title":"Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway","volume":"70","author":"Higgs","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib59","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/annrheumdis-2019-216379","article-title":"IFN-\u03b1 kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study","volume":"79","author":"Houssiau","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib60","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/ni828","article-title":"Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation","volume":"3","author":"Hu","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib61","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/art.21890","article-title":"Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies","volume":"54","author":"Hua","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib62","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2017-212379","article-title":"DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus","volume":"77","author":"Imgenberg-Kreuz","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib63","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/annrheumdis-2015-208659","article-title":"Genome-wide DNA methylation analysis in multiple tissues in primary Sj\u00f6gren's syndrome reveals regulatory effects at interferon-induced genes","volume":"75","author":"Imgenberg-Kreuz","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib64","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ng.81","article-title":"Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci","volume":"40","author":"Harley","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2021.11.031_bib65","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/art.24600","article-title":"Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population","volume":"60","author":"Ito","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib66","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib67","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1600-0625.2009.00982.x","article-title":"Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus","volume":"19","author":"J\u00e4rvinen","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2021.11.031_bib68","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.trsl.2014.10.002","article-title":"Interferon regulatory factors: critical mediators of human lupus","volume":"165","author":"Jensen","year":"2015","journal-title":"Transl Res"},{"key":"10.1016\/j.jid.2021.11.031_bib69","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1172\/JCI79100","article-title":"Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations","volume":"124","author":"Jeremiah","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2021.11.031_bib70","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1038\/s41467-019-10242-9","article-title":"Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus","volume":"10","author":"Jiang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2021.11.031_bib71","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/annrheumdis-2014-206090","article-title":"A\u00a0phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-\u03b1) in patients with systemic lupus erythematosus (ROSE)","volume":"75","author":"Kalunian","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib72","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/gene.2014.57","article-title":"Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus","volume":"16","author":"Kariuki","year":"2015","journal-title":"Genes Immun"},{"key":"10.1016\/j.jid.2021.11.031_bib73","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4049\/jimmunol.182.1.34","article-title":"Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in\u00a0vivo","volume":"182","author":"Kariuki","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib74","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/gene.2009.15","article-title":"Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus","volume":"10","author":"Kariuki","year":"2009","journal-title":"Genes Immun"},{"key":"10.1016\/j.jid.2021.11.031_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf8442","article-title":"Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus","volume":"13","author":"Karnell","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2021.11.031_bib76","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ni1303","article-title":"Innate immune recognition of viral infection","volume":"7","author":"Kawai","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib77","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1136\/annrheumdis-2015-208562","article-title":"Sifalimumab, an anti-interferon-\u03b1 monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study","volume":"75","author":"Khamashta","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib78","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib79","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/annrheumdis-2016-209841","article-title":"Familial chilblain lupus due to a gain-of-function mutation in STING","volume":"76","author":"K\u00f6nig","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib80","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/jamainternmed.2015.3528","article-title":"Familial aggregation of systemic lupus erythematosus and coaggregation of autoimmune diseases in affected families","volume":"175","author":"Kuo","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jid.2021.11.031_bib81","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.4049\/jimmunol.1303400","article-title":"X-chromosome complement and estrogen receptor signaling independently contribute to the enhanced TLR7-mediated IFN-\u03b1 production of plasmacytoid dendritic cells from women","volume":"193","author":"Laffont","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib82","doi-asserted-by":"crossref","first-page":"39765","DOI":"10.1074\/jbc.M102502200","article-title":"Interferon-kappa, a novel type I interferon expressed in human keratinocytes","volume":"276","author":"LaFleur","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2021.11.031_bib83","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000285","article-title":"DNA methylation 101: what is important to know about DNA methylation and its role in SLE risk and disease heterogeneity","volume":"5","author":"Lanata","year":"2018","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.jid.2021.11.031_bib84","first-page":"913","article-title":"A\u00a0family survey of lupus erythematosus. 1. Heritability","volume":"14","author":"Lawrence","year":"1987","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib85","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00109-007-0199-9","article-title":"A\u00a0mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus","volume":"85","author":"Lee-Kirsch","year":"2007","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.jid.2021.11.031_bib86","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/cmi.2018.7","article-title":"The microbiome and autoimmunity: a paradigm from the gut-liver axis","volume":"15","author":"Li","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib87","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1159\/000495897","article-title":"Type I interferons: distinct biological activities and current applications for viral infection","volume":"51","author":"Li","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jid.2021.11.031_bib88","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.3643","article-title":"A\u00a0gene network regulated by the transcription factor VGLL3 as a promoter of sex-biased autoimmune diseases","volume":"18","author":"Liang","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib89","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/ard.2010.139949","article-title":"Interferon \u03b2 is associated with type 1 interferon-inducible gene expression in dermatomyositis","volume":"70","author":"Liao","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib90","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.chom.2008.11.008","article-title":"Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor","volume":"5","author":"Liu","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jid.2021.11.031_bib91","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.39560","article-title":"X\u00a0chromosome dose and sex bias in autoimmune diseases: increased prevalence of 47,XXX in systemic lupus erythematosus and Sj\u00f6gren's syndrome","volume":"68","author":"Liu","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib92","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/art.37742","article-title":"Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis","volume":"65","author":"Liu","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib93","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.11.031_bib94","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1136\/annrheumdis-2019-215571","article-title":"Ultrasensitive serum interferon-\u03b1 quantification during SLE remission identifies patients at risk for relapse","volume":"78","author":"Mathian","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib95","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cyto.2017.02.006","article-title":"Interferon regulatory factor signaling in autoimmune disease","volume":"98","author":"Matta","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.jid.2021.11.031_bib96","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/art.39795","article-title":"Expression of long interspersed nuclear element 1 retroelements and induction of type I interferon in patients with systemic autoimmune disease","volume":"68","author":"Mavragani","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib97","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/cmi.2016.25","article-title":"Clash of the cytokine titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses","volume":"14","author":"Mayer-Barber","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib98","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1600-0560.2007.00848.x","article-title":"Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus","volume":"35","author":"McNiff","year":"2008","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jid.2021.11.031_bib99","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1002\/art.23142","article-title":"Association of an IRF5 gene functional polymorphism with Sj\u00f6gren's syndrome","volume":"56","author":"Miceli-Richard","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib100","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/art.40800","article-title":"Muscle expression of type I and type II interferons is increased in juvenile dermatomyositis and related to clinical and histologic features","volume":"71","author":"Moneta","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib101","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.11.031_bib102","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s10020-020-00256-1","article-title":"Escape from X chromosome inactivation and female bias of autoimmune diseases","volume":"26","author":"Mousavi","year":"2020","journal-title":"Mol Med"},{"key":"10.1016\/j.jid.2021.11.031_bib103","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1136\/annrheumdis-2015-208140","article-title":"Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification","volume":"75","author":"Munroe","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib104","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/sj.gene.6364408","article-title":"High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus","volume":"8","author":"Niewold","year":"2007","journal-title":"Genes Immun"},{"key":"10.1016\/j.jid.2021.11.031_bib105","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/art.24555","article-title":"Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy","volume":"60","author":"Niewold","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib106","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jpeds.2010.04.034","article-title":"Gene-gene-sex interaction in cytokine gene polymorphisms revealed by serum interferon alpha phenotype in juvenile dermatomyositis","volume":"157","author":"Niewold","year":"2010","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jid.2021.11.031_bib107","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/art.23613","article-title":"Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients","volume":"58","author":"Niewold","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib108","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/annrheumdis-2011-200463","article-title":"IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus","volume":"71","author":"Niewold","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib109","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1542\/peds.2010-3022","article-title":"Familial aggregation of autoimmune disease in juvenile dermatomyositis","volume":"127","author":"Niewold","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jid.2021.11.031_bib110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajhg.2014.06.007","article-title":"Aicardi-Gouti\u00e8res syndrome is caused by IFIH1 mutations","volume":"95","author":"Oda","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jid.2021.11.031_bib111","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1038\/s41467-019-10106-2","article-title":"Interferon inducible X-linked gene CXorf21 may contribute to sexual dimorphism in systemic lupus erythematosus","volume":"10","author":"Odhams","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2021.11.031_bib112","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13075-019-1878-y","article-title":"High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus","volume":"21","author":"Oke","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jid.2021.11.031_bib113","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/rheumatology\/key386","article-title":"The relationship between type 1 IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients [published correction appears in Rheumatology (Oxford) 2020;59:918]","volume":"58","author":"Ono","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jid.2021.11.031_bib114","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/art.41602","article-title":"Study of tofacitinib in refractory dermatomyositis: an open-label pilot study of ten patients","volume":"73","author":"Paik","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib115","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/13543784.2020.1797677","article-title":"Type I interferon antagonists in clinical development for lupus","volume":"29","author":"Paredes","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jid.2021.11.031_bib116","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib117","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coi.2020.10.014","article-title":"Type I interferon in the pathogenesis of systemic lupus erythematosus","volume":"67","author":"Postal","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib118","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1038\/s41467-020-19918-z","article-title":"Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity","volume":"11","author":"Psarras","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2021.11.031_bib119","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.565","article-title":"Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus","volume":"42","author":"Radstake","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2021.11.031_bib120","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/annrheumdis-2018-214620","article-title":"Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus","volume":"78","author":"Rahman","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib121","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.immuni.2018.12.027","article-title":"Plasmacytoid dendritic cells: development, regulation, and function","volume":"50","author":"Reizis","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2021.11.031_bib122","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa073003","article-title":"STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus","volume":"357","author":"Remmers","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.11.031_bib123","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/521373","article-title":"Clinical and molecular phenotype of Aicardi-Goutieres syndrome","volume":"81","author":"Rice","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jid.2021.11.031_bib124","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.4049\/jimmunol.1100857","article-title":"Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-\u03b1 and serologic autoimmunity in lupus patients","volume":"187","author":"Robinson","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib125","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/annrheumdis-2020-218439","article-title":"Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma","volume":"80","author":"Ross","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib126","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaut.2016.06.009","article-title":"A\u00a0clinical update on the significance of the gut microbiota in systemic autoimmunity","volume":"74","author":"Rosser","year":"2016","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jid.2021.11.031_bib127","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/art.41737","article-title":"Regulation of monocyte adhesion and type I interferon signaling by CD52 in patients with systemic sclerosis","volume":"73","author":"Rudnik","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib128","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/hmg\/ddp119","article-title":"The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype","volume":"18","author":"Rueda","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jid.2021.11.031_bib129","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/art.27182","article-title":"Genetic variation at the IRF7\/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients","volume":"62","author":"Salloum","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib130","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1128\/MCB.00224-09","article-title":"Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18\/UBP43","volume":"29","author":"Sarasin-Filipowicz","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jid.2021.11.031_bib131","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/annrheumdis-2018-213197","article-title":"Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa","volume":"77","author":"Sarkar","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib132","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1002\/art.23701","article-title":"Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome","volume":"58","author":"Scofield","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib133","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood-2011-08-371831","article-title":"The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in\u00a0vivo through cell-intrinsic estrogen receptor \u03b1 signaling","volume":"119","author":"Seillet","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jid.2021.11.031_bib134","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1002\/art.27529","article-title":"Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells","volume":"62","author":"Shrestha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib135","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type 1 interferon-producing cells in human blood","volume":"284","author":"Siegal","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jid.2021.11.031_bib136","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1093\/hmg\/ddn184","article-title":"A\u00a0risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5","volume":"17","author":"Sigurdsson","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jid.2021.11.031_bib137","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/428480","article-title":"Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus","volume":"76","author":"Sigurdsson","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jid.2021.11.031_bib138","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41584-018-0152-z","article-title":"The microbiome in SLE pathogenesis","volume":"15","author":"Silverman","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib139","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/acr.23931","article-title":"Familial aggregation of childhood- and adulthood-onset systemic lupus erythematosus","volume":"72","author":"Sinicato","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jid.2021.11.031_bib140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cell.2016.05.034","article-title":"Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity","volume":"166","author":"Sisirak","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jid.2021.11.031_bib141","doi-asserted-by":"crossref","first-page":"154635","DOI":"10.1016\/j.cyto.2018.12.018","article-title":"Type I interferon dysregulation in systemic sclerosis","volume":"132","author":"Skaug","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.jid.2021.11.031_bib142","doi-asserted-by":"crossref","first-page":"7908","DOI":"10.1038\/s41598-020-64865-w","article-title":"The early local and systemic type I interferon responses to ultraviolet B light exposure are cGAS dependent","volume":"10","author":"Skopelja-Gardner","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2021.11.031_bib143","first-page":"625","article-title":"Systemic sclerosis developing in association with the use of interferon alpha therapy for chronic viral hepatitis","volume":"22","author":"Solans","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.04.015","article-title":"Plasmacytoid dendritic cells and type I interferon promote extrafollicular B cell responses to extracellular self-DNA","volume":"52","author":"Soni","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2021.11.031_bib145","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3389\/fimmu.2019.01601","article-title":"Self-DNA at the epicenter of SLE: immunogenic forms, regulation, and effects","volume":"10","author":"Soni","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib146","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/art.39987","article-title":"Ultraviolet B irradiation causes stimulator of interferon genes-dependent production of protective type I interferon in mouse skin by recruited inflammatory monocytes","volume":"69","author":"Sontheimer","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib147","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3899\/jrheum.090823","article-title":"Lack of interaction between systemic lupus erythematosus-associated polymorphisms in TYK2 and IRF5","volume":"37","author":"Suarez-Gestal","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib148","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00011-015-0865-2","article-title":"Genetic association and interaction between the IRF5 and TYK2 genes and systemic lupus erythematosus in the Han Chinese population","volume":"64","author":"Tang","year":"2015","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jid.2021.11.031_bib149","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/ni1126","article-title":"Amplification of IFN-alpha-induced STAT1 activation and inflammatory function by Syk and ITAM-containing adaptors","volume":"5","author":"Tassiulas","year":"2004","journal-title":"Nat Immunol"},{"issue":"Suppl.3","key":"10.1016\/j.jid.2021.11.031_bib150","first-page":"536","article-title":"SAT0193resultsof a randomized placebo controlled phase ia study of AGS -009,a humanized anti -interferon-\u03b1monoclonal antibody in subjects with systemic lupus erythematosus","volume":"71","author":"Tcherepanova","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.11.031_bib151","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/acr2.11073","article-title":"Type I interferon predicts an alternate immune system phenotype in systemic lupus erythematosus","volume":"1","author":"Thanarajasingam","year":"2019","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.jid.2021.11.031_bib152","doi-asserted-by":"crossref","first-page":"595811","DOI":"10.3389\/fimmu.2021.595811","article-title":"Disparate interferon signaling and shared aberrant basaloid cells in single-cell profiling of idiopathic pulmonary fibrosis and systemic sclerosis-associated interstitial lung disease","volume":"12","author":"Valenzi","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib153","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2018.10.009","article-title":"Shared gut, but distinct oral microbiota composition in primary Sj\u00f6gren's syndrome and systemic lupus erythematosus","volume":"97","author":"van der Meulen","year":"2019","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jid.2021.11.031_bib154","first-page":"1563","article-title":"Proteome-wide analysis and CXCL4 in systemic sclerosis","volume":"370","author":"van Roon","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.11.031_bib155","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(18)31363-1","article-title":"Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial [published correction appears in Lancet 2018;392:476","volume":"392","author":"Wallace","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2021.11.031_bib156","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib157","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/art.30187","article-title":"Network analysis of associations between serum interferon-\u03b1 activity, autoantibodies, and clinical features in systemic lupus erythematosus","volume":"63","author":"Weckerle","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib158","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12016-009-8192-4","article-title":"The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies","volume":"40","author":"Weckerle","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jid.2021.11.031_bib159","article-title":"Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2021.11.031_bib160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.coviro.2015.04.004","article-title":"How RIG-I like receptors activate MAVS","volume":"12","author":"Wu","year":"2015","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jid.2021.11.031_bib161","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/art.22382","article-title":"A\u00a0macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists [published correction appears in Arthritis Rheum 2007;56:1675","volume":"56","author":"York","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2021.11.031_bib162","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-021-00554-y","article-title":"Cytosolic DNA sensing by cGAS: regulation, function, and human diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jid.2021.11.031_bib163","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.immuni.2016.06.021","article-title":"Antimicrobial peptide LL37 and MAVS signaling drive interferon-\u03b2 production by epidermal keratinocytes during skin injury","volume":"45","author":"Zhang","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2021.11.031_bib164","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/bjd.16917","article-title":"Aberrant activation of the type I interferon system may contribute to the pathogenesis of anti-melanoma differentiation-associated gene 5 dermatomyositis","volume":"180","author":"Zhang","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2021.11.031_bib165","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/molbev\/mst148","article-title":"Genes that escape X-inactivation in humans have high intraspecific variability in expression, are associated with mental impairment but are not slow evolving [published correction appears in Mol Biol Evol 2016;33:302]","volume":"30","author":"Zhang","year":"2013","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.jid.2021.11.031_bib166","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.humimm.2013.04.034","article-title":"Meta-analysis reveals an association of STAT4 polymorphisms with systemic autoimmune disorders and anti-dsDNA antibody","volume":"74","author":"Zheng","year":"2013","journal-title":"Hum Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21026063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21026063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:54:34Z","timestamp":1778709274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X21026063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":166,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0022202X21026063"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2021.11.031","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type I Interferons in Autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2021.11.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}